Colorectal Cancer Trial, Recruiting NCT07046585 Sponsor: Natera, Inc. Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT07046585
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are aged 40 or older at the time of signing the consent form
  • People who are already planning to have a routine colonoscopy as part of their normal medical care
  • People who are able to have blood drawn through a needle in a vein
  • People who are able to provide blood samples within the 120 days before their bowel preparation and colonoscopy procedures
  • People who are willing and able to follow the study visit schedule and meet the study requirements
  • People who have signed the informed consent form for the study

Who may not be able to join:

  • People who have had any type of cancer in the past (except those who had squamous cell or basal cell skin cancers surgically removed at least 12 months before signing consent)
  • People who have had a full colonoscopy with adequate bowel preparation within the last 9 years
  • People who are having a colonoscopy to investigate specific symptoms they are experiencing
  • People who are already up to date with bowel cancer screening through a non-invasive test
  • People whose most recent colonoscopy found precancerous growths or changes
  • People who have previously had part of their bowel/colon removed for any reason other than a condition called sigmoid diverticular disease
  • People with a known personal history of inflammatory bowel disease (such as Crohn's disease or ulcerative colitis)
  • People with a known hereditary condition that increases the risk of bowel cancer, such as Lynch Syndrome

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 650-489-9050

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Natera, Inc.
Registry
ClinicalTrials.gov
Start date
30 May 2025
Est. completion
10 July 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Primary Outcome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov